Must-have Thalidomide-propargyl-c1-oh Device [4XRdftZw]

Thalidomide-Propargyl-C1-OH: A Game-Changing Degradation Building Block

Thalidomide-Propargyl-C1-OH is a revolutionary degrader building block designed for targeted protein degradation. This innovative compound boasts a unique structure that combines the efficacy of a thalidomide core with a propargyl group and a hydroxyl function, making it an invaluable tool in the field of protein degradation research. Its core features include a highly effective E3 ligase ligand, a versatile linker, and a functional group that can be easily conjugated to target protein ligands through straightforward chemical reactions.

Key Product Properties and Specifications

Thalidomide-Propargyl-C1-OH is formulated with a molecular formula of C17H14N2O5 and a molecular weight of 326.308. The product boasts an impressive purity of >= 95% as determined by HPLC analysis. It is supplied in a convenient form for room temperature shipping and can be stored refrigerated to maintain its stability. With a shelf life of 12 months after delivery, this product is designed to provide researchers with a reliable and long-lasting solution for their protein degradation studies.

Practical Applications and Target Audience

Thalidomide-Propargyl-C1-OH is an indispensable tool for researchers working in the field of targeted protein degradation. Its unique properties make it particularly useful in the development of novel therapies for diseases caused by misfolded or overexpressed proteins. This product is ideal for a wide range of applications, including the study of protein-protein interactions, the discovery of new drug targets, and the development of targeted protein degradation therapies. By using Thalidomide-Propargyl-C1-OH, researchers can unlock the full potential of protein degradation as a therapeutic strategy, ultimately leading to advancements in the treatment of various diseases.